Literature DB >> 23626902

The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia.

Suhad M Bahijri1, Rajaa M Al Raddadi.   

Abstract

The clustering of risk factors predisposing an individual to cardiovascular morbidity and mortality are usually referred to as the 'metabolic syndrome' (MS). Several definitions exist, causing confusion to practicing clinicians. A consensus definition was reached by several major organizations stating that the presence of any three of five risk factors (abdominal obesity, elevated triglyceride, reduced high-density lipoprotein cholesterol, elevated blood pressure, and elevated fasting glucose) constitutes a diagnosis. Cutoff points for each of the risk factors were defined, taking into account ethnicity in case of abdominal obesity. The prevalence of MS has been reported to be on the rise globally, and was mainly attributed to changes in diet and lifestyle, in addition to genetic factors and metabolic susceptibility. The risk of cardiovascular disease (CVD) has almost doubled and the risk of developing type 2 diabetes mellitus (T2DM) has increased fivefold in individuals diagnosed with MS. The prevalence T2DM in Saudi Arabia is increasing, making it an epidemic health hazard. Intervention programs to decrease the risk of progression from MS to full T2DM, and later CVD have been successful in many countries. Therefore, diagnosing MS is important to address risk factors and to prevent progression to the more serious chronic conditions. The prevalence of MS in Saudi adults varies from 16% to 40% depending on the definition used and the study location. Use of the consensus definition might decrease the number of missed cases. However, in the absence of local cutoff points for various risk factors for MS, the use of ratios such as waist/hip ratio and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio, and family history of diabetes and CVD might aid diagnosis. Priority should be given to establishing national normal ranges, screening programs for hyperglycemia and hypertension, and community-directed programs to combat obesity and inactivity.

Entities:  

Keywords:  Saudis; criteria; definition; metabolic syndrome; prevalence

Year:  2013        PMID: 23626902      PMCID: PMC3632005          DOI: 10.1177/2042018813483165

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  42 in total

1.  Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia.

Authors:  A R Al-Nuaim
Journal:  Diabet Med       Date:  1997-07       Impact factor: 4.359

2.  Prevalence of metabolic syndrome in Saudi adult soldiers.

Authors:  Dhafer A Al-Qahtani; Mohammed L Imtiaz
Journal:  Saudi Med J       Date:  2005-09       Impact factor: 1.484

3.  Mainstreaming the metabolic syndrome: a definitive definition.

Authors:  Paul Z Zimmet; K George M M Alberti; Jonathan E Shaw
Journal:  Med J Aust       Date:  2005-08-15       Impact factor: 7.738

Review 4.  Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project?

Authors:  Sophia Papadakis; Isabella Moroz
Journal:  Curr Opin Cardiol       Date:  2008-09       Impact factor: 2.161

5.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

7.  Prevalence of metabolic syndrome among qassim university personnel in saudi arabia.

Authors:  Issam E Barrimah; Abdul Rahman Mohaimeed; Farid Midhat; Hani A Al-Shobili
Journal:  Int J Health Sci (Qassim)       Date:  2009-07

Review 8.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

9.  Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.

Authors:  Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  BMC Public Health       Date:  2010-09-02       Impact factor: 3.295

10.  Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10.

Authors:  M Stumvoll; H G Wahl; F Machicao; H Häring
Journal:  Diabetologia       Date:  2002-04-04       Impact factor: 10.122

View more
  11 in total

1.  Modulation of Dyslipidemia Markers Apo B/Apo A and Triglycerides/HDL-Cholesterol Ratios by Low-Carbohydrate High-Fat Diet in a Rat Model of Metabolic Syndrome.

Authors:  Abrar Alnami; Abdulhadi Bima; Aliaa Alamoudi; Basmah Eldakhakhny; Hussein Sakr; Ayman Elsamanoudy
Journal:  Nutrients       Date:  2022-05-01       Impact factor: 6.706

Review 2.  The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A Meta-Analysis.

Authors:  Abdel Hamid El Bilbeisi; Sakineh Shab-Bidar; Diane Jackson; Kurosh Djafarian
Journal:  Ethiop J Health Sci       Date:  2017-01

3.  Anthropometric cutoff values for predicting metabolic syndrome in a Saudi community: from the SAUDI-DM study.

Authors:  Khalid Al-Rubean; Amira M Youssef; Yousuf AlFarsi; Ahmad H Al-Sharqawi; Nahla Bawazeer; Mohammad T AlOtaibi; Fahd Issa AlRumaih; Muhammad Shoaib Zaidi
Journal:  Ann Saudi Med       Date:  2017 Jan-Feb       Impact factor: 1.526

4.  Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.

Authors:  Maryam N Alotibi; Amina M Alnoury; Amani M Alhozali
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

5.  Postpartum Weight Retention and Cardiometabolic Risk among Saudi Women: A Follow-Up Study of RAHMA Subcohort.

Authors:  Hayfaa A Wahabi; Amel A Fayed; Shabana Tharkar; Samia A Esmaeil; Hanadi Bakhsh
Journal:  Biomed Res Int       Date:  2019-07-01       Impact factor: 3.411

6.  Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients.

Authors:  Mohamed Bakr Zaki; Ahmed Ibrahim Abulsoud; Ahmed Mohamed Elsisi; Ahmed Soliman Doghish; Ossama Abd Elmotaal Mansour; Ashraf Ismail Amin; Mahmoud Ahmed Elrebehy; Mohamed Yousef Mohamed; Mohamed Ahmed Goda
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-06       Impact factor: 3.168

7.  The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia.

Authors:  Turki Al Amri; Suhad Bahijri; Rajaa Al-Raddadi; Ghada Ajabnoor; Jawaher Al Ahmadi; Hanan Jambi; Anwar Borai; Jaakko Tuomilehto
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-24       Impact factor: 3.168

8.  The Prevalence of Diabetes and Prediabetes in the Adult Population of Jeddah, Saudi Arabia--A Community-Based Survey.

Authors:  Suhad M Bahijri; Hanan A Jambi; Rajaa M Al Raddadi; Gordon Ferns; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

Review 9.  Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.

Authors:  Ibrahim M Gosadi
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

10.  Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women.

Authors:  Sameer H Fatani; Nazik Altayeb Abdelbasit; Hiba S Al-Amodi; Maowia Mohamed Mukhtar; Abdullatif Taha Babakr
Journal:  Diabetes Metab Syndr Obes       Date:  2018-05-01       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.